NHS prescribing intelligence on inhalers, spacers, drugs and other devices used in asthma and COPD

The management of respiratory conditions represents a significant percentage of UK community prescribing.With increased NHS focus on the safe and appropriate prescribing of inhaled medicines, GPrX includes a specific respiratory dashboard benchmarking SABA rates at practice level against local and national comparators.

Select from our RxIndexes to see the top-line brand market share movement of some of the most commonly-prescribed inhalers. Full breakdown and trends are available with a GPrX login.


GPrX Data Ltd

Additional resources on prescribing for respiratory conditions

Click below for some of GPrX's content around this therapy area

Ready to start the conversation?

Our friendly team loves talking data. Schedule a chat or an online demo now!